Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Zollinger-Ellison syndrome epidemiology and demographics
Introduction
Overview
Overview
The incidence of gastrinoma, which can cause Zollinger-Ellison syndrome, is approximately 0.05 – 0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 (MEN1).
Epidemiology and Demographics
Epidemiology and Demographics
Incidence
- The worldwide incidence of gastrinomas is about 5 to 30 cases per 100,000 individuals per year.[1]
- With improved techniques for tumor detection, the annual incidence has increased.
- About 80% to 90% of these tumors arise in the gastrinoma triangle.
Age
- Zollinger-Ellison syndrome is a disease that tends to affect the middle-aged adult population (20 – 50 years of age).[2]
Gender
- Males are more commonly affected with Zollinger-Ellison syndrome than females.[2]
Race
- There is no racial predilection to Zollinger-Ellison syndrome
References
References
- ↑ Cingam SR, Karanchi H. PMID 28722872. Missing or empty
|title=(help) - ↑ 2.0 2.1 Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006). “Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature”. Medicine (Baltimore). 85 (6): 295–330. doi:10.1097/01.md.0000236956.74128.76. PMID 17108778.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]